Topical Finasteride in the Treatment of Idiopathic NCT00564252

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Completed

Study information
Verified date	November 2007
Source	Iran University of Medical Sciences
Contact	n/a
Is FDA regulated	No
Health authority	Iran: Ethics Committee
Study type	Interventional

the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism

Recruitment information / eligibility
Status	Completed
Enrollment	56
Est. completion date	October 2006
Est. primary completion date
Accepts healthy volunteers	No
Gender	Female
Age group	N/A and older
Eligibility	Inclusion Criteria: - Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation - Normal serum prolactin Exclusion Criteria: - Pregnancy - Simultaneous use of other drugs for the treatment of hirsutism

Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Drug:
• topical finasteride
0.2%topical(cream)finasteride twice a day for six months

Locations
Country	Name	City	State
n/a

Sponsors *(2)*
Lead Sponsor	Collaborator
Iran University of Medical Sciences	Firuzgar hospital affiliated to Iran University of Medical Sciences

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication		6 months
Secondary	the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication		6 months